查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1563832

全球生育治療服務市場

Fertility Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球生育服務市場將達到 1,242 億美元

全球生育服務市場預計 2023 年為 470 億美元，預計到 2030 年將達到 1,242 億美元，2023-2030 年分析期間複合年成長率為 14.9%。易腐非捐助服務是本報告分析的細分市場之一，預計複合年成長率為 16.1%，到分析期結束時將達到 753 億美元。分析期間，冷凍的非捐贈服務業的複合年成長率預計為 13.7%。

美國市場預計121億美元，中國預計複合年成長率19.3%

預計 2023 年美國生育服務市場規模將達 121 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達317億美元，2023-2030年分析期間複合年成長率為19.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 10.2% 和 12.6%。在歐洲，德國預計複合年成長率為 11.4%。

全球生育治療服務市場－主要趨勢與促進因素總結

生育服務如何徹底改變生殖健康和計劃生育？

生育服務透過為面臨生育挑戰的個人和夫婦提供先進的醫療干預措施和個人化護理，正在改變生殖健康和計劃生育。隨著人們對不孕症治療的認知和接受度不斷提高，體外受精 (IVF)、卵子冷凍和基因篩檢等輔助生殖技術 (ART) 的進步為世界各地數百萬人帶來了希望。生育服務包括幫助診斷和治療不孕症、支持計劃生育、提高生育能力等的各種治療方法。這些服務正在成為現代醫療保健不可或缺的一部分，使個人和夫婦能夠實現成為父母的夢想，而不受年齡、醫療狀況和其他因素的影響。

近年來，晚育、生活方式改變、不孕率上升等社會變化，增加了對不孕症治療服務的需求。我們的不孕症診所提供廣泛的服務，從不孕不育評估和荷爾蒙治療到尖端的 ART 治療。冷凍卵子的興起是一種日益成長的趨勢，特別是對於那些希望為未來懷孕保留生育能力的女性。生育服務的擴展不僅使個人能夠控制自己的生殖健康，而且使計劃生育變得更加容易和全面，特別是對於同性伴侶、單親父母和麵臨生殖健康挑戰的人。隨著不孕症治療的進步並變得越來越被社會接受，這些服務在人們規劃家庭的方式方面發揮著變革性的作用。

為什麼生育服務對於解決生殖挑戰和擴大計劃生育選擇很重要？

生育服務對於解決生殖挑戰和擴大計劃生育選擇非常重要，因為它們為面臨自然受孕障礙的個人和夫婦提供醫療解決方案。隨著不孕症盛行率的增加，影響了全球約 10-15% 的夫婦，生育服務透過診斷和治療阻礙懷孕的潛在疾病提供了希望和支持。由於年齡、荷爾蒙失調、遺傳因素、生活方式問題等，不孕症是精神和身體上的負擔。體外受精 (IVF)、子宮內人工授精 (IUI) 以及卵子或精子捐贈等生育治療可以幫助克服這些障礙並實現成功懷孕。

生育服務對於為沒有不孕症但正在尋求替代計劃生育手段的人們提供選擇也至關重要。出於個人或職業原因選擇推遲生育的女性現在可以訴諸卵子冷凍。此外，生育服務為 LGBTQ+ 個人和夫婦，以及需要捐卵子、捐精或代孕來建立家庭的單親父母提供重要選擇。這些服務確保為人父母不受生物學限制或傳統家庭結構的限制，提供更具包容性和多樣化的為人父母之路。

生育服務的另一個重要作用是解決卵巢症候群（PCOS）、子宮內膜異位症和男性不孕症等醫療問題，例如精子數量和活力低下。生育診所提供治療和介入措施，以增加您懷孕的機會。此外，基因篩檢和胚胎著床前基因檢測（PGT）的進步使得在懷孕前識別遺傳疾病成為可能，從而為父母和嬰兒帶來更健康的結果。這種全面的不孕症治療方法正在幫助更多的人克服複雜的生殖挑戰，並以以前不可能的方式擴大他們的家庭建設選擇。

不孕症治療服務在生殖健康方面有哪些拓展應用與創新？

由於醫療技術、遺傳學和個人化生殖醫學的突破，生育服務的應用和創新正在迅速擴大。生育服務最重要的進步之一是體外受精（IVF）的興起。體外受精是在體外使卵子受精並將受精卵植入子宮的方法。隨著技術的進步，體外受精的成功率不斷提高，使其成為治療方法之一。延時成像和胚胎監測系統等技術創新使胚胎學家能夠更準確地評估胚胎髮育，增加成功植入和懷孕的機會。

卵子和精子冷凍技術也顯著改進，增加了保留生育能力的機會。冷凍保存方法（包括玻璃化冷凍）可以使卵子和精子以更高的存活率冷凍，從而為個人提供延遲生育的靈活性。這對於可能化療而喪失生育能力的癌症患者以及出於個人或職業原因想要保留生育能力的女性尤其重要。此外，精子萃取技術的進步為精子數量低或有其他生育問題的男性提供了解決方案，使他們能夠透過輔助生殖技術懷孕。

生育服務領域的另一個令人興奮的創新是胚胎著床前基因檢測（PGT），它可以在胚胎著床前胚胎進行基因篩檢。 PGT可以檢測染色體異常和遺傳性疾病，如子宮蓄膿、鐮狀細胞性貧血和亨廷頓氏舞蹈病，確保在IVF期間僅移植健康的胚胎。這項技術不僅增加了成功懷孕的機會，也降低了孩子流產和遺傳疾病的風險。遺傳諮詢現已成為生育服務不可或缺的一部分，使夫婦能夠根據自己的遺傳傾向就其生育選擇做出明智的決定。

除了這些技術進步之外，生育服務正在擴展到更全面的生殖醫學方法。認知到解決生育治療的情緒、身體和心理方面的重要性，診所擴大提供支持服務，例如生育指導、營養指導、心理健康諮詢和針灸。生育診所也正在採用數位健康工具，遠端醫療諮詢、生育追蹤應用程式和遠端監控變得越來越普遍。這種以患者為中心的照護的轉變正在幫助人們以更大的支持和便利性來應對不孕不育治療的複雜過程。

生育服務創新的另一個領域是在生育治療中擴大使用人工智慧（AI）和機器學習。人工智慧驅動的系統被用來分析患者資訊、胚胎發育和治療結果等大型資料集，幫助醫生就生育治療計劃做出更準確的決策。例如，人工智慧可以根據患者的病歷、遺傳學和胚胎品質來預測試管嬰兒週期的成功率，從而實現更個人化和更​​有效的治療策略。這些創新使不孕症治療更有效率、便利性和成功，為想要建立家庭的個人和夫妻帶來了新的可能性。

推動不孕症治療服務市場成長的因素有哪些？

不孕症服務市場的成長有幾個關鍵因素，包括不孕症盛行率上升、生育延遲、生殖技術的進步以及社會對不孕症治療的接受度不斷提高。主要促進因素之一是全球不孕症的增加，這對男性和女性都有影響。生活方式的改變、環境污染物、壓力、肥胖和卵巢症候群（PCOS）等醫療狀況等因素導致不孕率上升。隨著越來越多的人面臨自然受孕困難，對不孕不育服務的需求持續成長，體外受精、人工授精和生育力保存等治療變得越來越普遍。

促進不孕症治療服務市場成長的另一個重要因素是延遲生育的趨勢。隨著越來越多的女性優先考慮職業、教育和個人目標，許多女性選擇在晚年生孩子。然而，年齡是不孕症的重要因素，尤其是對女性來說，因為生育力隨著年齡的成長而下降。生育治療服務，包括卵子冷凍和體外受精，為希望保留生育能力並在以後懷孕的女性提供解決方案，從而導致對這些服務的需求增加。此外，隨著再婚和混合家庭的增加，希望共同生育孩子的老年人和夫婦正在利用不孕症服務，進一步推動市場成長。

生殖技術的進步也在擴大不孕症治療服務市場方面發揮重要作用。胚胎著床前基因檢測（PGT）、延時胚胎成像和冷凍保存技術等創新治療方法正在提高不孕症治療的成功率，並使其對尋求輔助生殖的個人和夫婦更具吸引力。人工智慧和機器學習在生育診所的整合透過提供更個人化的護理和最佳化治療策略進一步改善治療結果。這些技術進步使不孕症治療更有效和方便，鼓勵更多的人探索生育治療方案。

社會對不孕症治療的接受度不斷提高也是推動市場成長的主要因素。曾經被認為是禁忌和污名化的不孕症治療現在已被廣泛接受和接受，尤其是在已開發國家。公眾人物和名人公開談論不孕症治療正在減少不孕不育的恥辱，並鼓勵更多的人尋求不孕症治療。此外，法律和社會進步，例如對同性婚姻的核准以及代孕和捐贈計劃的可用性，正在為 LGBTQ+ 個人和單親父母建立家庭提供新的途徑。隨著不孕症治療變得更加容易取得和常規化，不孕症治療服務的市場不斷擴大。

政府對不孕症治療的支持和擴大醫療保健覆蓋範圍也推動了市場成長。在許多國家，保險公司和醫療保健系統已經開始承擔與試管受精等不孕症治療相關的一些費用，使更多人能夠負擔得起。政府促進生殖健康和為不孕症治療提供財政支持的努力也有助於增加獲得這些服務的機會。在出生率下降的地區，政府正在投資不孕症治療，作為國家促進人口成長努力的一部分，進一步促進市場擴張。

總而言之，隨著越來越多的個人和夫婦尋求輔助生殖來克服不孕症、推遲生育或尋求非傳統的家庭組成選擇，生育服務市場正在不斷成長，我們已經做好了顯著成長的準備。生殖技術的進步、社會接受度的提高以及生育服務機會的增加將使該行業在幫助人們實現生育夢想方面發揮更大的作用。隨著不孕症治療的不斷發展和改進，它們將提供更全面、有效和個人化的治療，這將徹底改變全球生殖健康和計劃生育的模式。

受訪企業範例（44家知名企業）

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP11932

Global Fertility Services Market to Reach US$124.2 Billion by 2030

The global market for Fertility Services estimated at US$47.0 Billion in the year 2023, is expected to reach US$124.2 Billion by 2030, growing at a CAGR of 14.9% over the analysis period 2023-2030. Fresh Non-Donor Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of the analysis period. Growth in the Frozen Non-Donor Services segment is estimated at 13.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.1 Billion While China is Forecast to Grow at 19.3% CAGR

The Fertility Services market in the U.S. is estimated at US$12.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$31.7 Billion by the year 2030 trailing a CAGR of 19.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.2% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.4% CAGR.

Global Fertility Services Market - Key Trends and Drivers Summarized

How Are Fertility Services Revolutionizing Reproductive Health and Family Planning?

Fertility services are transforming reproductive health and family planning by offering advanced medical interventions and personalized care to individuals and couples facing challenges in conceiving. With increasing awareness and acceptance of fertility treatments, advancements in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), egg freezing, and genetic screening, are giving hope to millions of people worldwide. Fertility services include a range of treatments that help diagnose and treat infertility, support family planning, and improve reproductive health. These services are becoming essential in the modern landscape of healthcare, allowing individuals and couples to realize their dreams of parenthood despite age, medical conditions, or other factors.

In recent years, the demand for fertility services has grown due to societal changes, such as delayed childbearing, lifestyle factors, and rising infertility rates. Fertility clinics now offer a wide array of services, from fertility assessments and hormonal treatments to cutting-edge ART procedures. The rise of egg freezing, particularly among women who wish to preserve their fertility for future pregnancies, has become a significant trend. This expansion of fertility services is not only empowering individuals to take control of their reproductive health but is also making family planning more accessible and inclusive, especially for same-sex couples, single parents, and those facing reproductive health challenges. As fertility treatments advance and societal acceptance grows, these services are playing a transformative role in how people plan their families.

Why Are Fertility Services Critical for Addressing Reproductive Challenges and Expanding Family Planning Options?

Fertility services are critical for addressing reproductive challenges and expanding family planning options because they offer medical solutions to individuals and couples who may face obstacles in conceiving naturally. With the increasing prevalence of infertility—affecting around 10-15% of couples globally—fertility services provide hope and support by diagnosing and treating underlying conditions that hinder conception. Whether due to age, hormonal imbalances, genetic factors, or lifestyle issues, infertility can be emotionally and physically taxing. Fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and egg or sperm donation enable people to overcome these barriers and achieve successful pregnancies.

Fertility services are also crucial in providing options for those who may not face infertility but are seeking alternatives for family planning. Women who choose to delay childbearing for personal or career reasons can now turn to egg freezing, which preserves their eggs at an optimal time, giving them the flexibility to conceive later in life. Additionally, fertility services offer crucial options for LGBTQ+ individuals and couples, as well as single parents, who may require donor eggs, sperm, or surrogacy to start a family. These services ensure that parenthood is not limited by biological constraints or traditional family structures, offering more inclusive and diverse pathways to having children.

Another key role of fertility services is in addressing medical conditions like polycystic ovary syndrome (PCOS), endometriosis, and male infertility issues such as low sperm count or motility. These conditions often go undiagnosed and untreated, but fertility clinics provide targeted treatments and interventions that increase the chances of conception. Furthermore, advancements in genetic screening and preimplantation genetic testing (PGT) allow for the identification of genetic disorders before pregnancy, ensuring healthier outcomes for both parents and babies. This comprehensive approach to fertility care is helping more people navigate complex reproductive challenges and expand their family-building options in ways that were not possible before.

What Are the Expanding Applications and Innovations in Fertility Services Across Reproductive Health?

The applications and innovations in fertility services are rapidly expanding, driven by breakthroughs in medical technology, genetics, and personalized reproductive care. One of the most significant advancements in fertility services is the rise of in vitro fertilization (IVF), which has revolutionized how couples and individuals approach infertility. IVF involves the fertilization of an egg outside the body, followed by the implantation of the embryo into the uterus. As technology improves, success rates for IVF have increased, making it one of the most effective treatments for infertility. Innovations such as time-lapse imaging and embryo monitoring systems allow embryologists to assess the development of embryos with greater precision, improving the chances of successful implantation and pregnancy.

Egg and sperm freezing technologies have also seen significant improvements, providing more opportunities for fertility preservation. Cryopreservation methods, including vitrification, have made it possible to freeze eggs and sperm with higher survival rates, offering individuals the flexibility to delay parenthood. This is particularly important for cancer patients who may face fertility loss due to chemotherapy, as well as women who want to preserve their fertility for personal or professional reasons. Additionally, advancements in sperm extraction techniques have provided solutions for men with low sperm counts or other fertility issues, allowing them to conceive through assisted reproductive technologies.

Another groundbreaking innovation in fertility services is preimplantation genetic testing (PGT), which allows for the genetic screening of embryos before implantation. PGT can detect chromosomal abnormalities or genetic disorders such as cystic fibrosis, sickle cell anemia, and Huntington’s disease, ensuring that only healthy embryos are transferred during IVF. This technology not only increases the chances of a successful pregnancy but also reduces the risk of miscarriage and genetic diseases in the child. Genetic counseling is now an integral part of fertility services, allowing couples to make informed decisions about their reproductive options based on their genetic makeup.

In addition to these technological advancements, fertility services are expanding to include a more holistic approach to reproductive health. Clinics are increasingly offering support services such as fertility coaching, nutritional guidance, mental health counseling, and acupuncture, recognizing the importance of addressing the emotional, physical, and psychological aspects of fertility treatment. Fertility clinics are also embracing digital health tools, with telemedicine consultations, fertility tracking apps, and remote monitoring becoming more common. This shift toward patient-centered care is helping individuals navigate the complex fertility journey with greater support and convenience.

Another area of innovation in fertility services is the growing use of artificial intelligence (AI) and machine learning in fertility treatments. AI-powered systems are being used to analyze large datasets of patient information, embryo development, and treatment outcomes, helping doctors make more accurate decisions about fertility treatment plans. For example, AI can be used to predict the success rates of IVF cycles based on patient history, genetics, and embryo quality, allowing for more personalized and effective treatment strategies. These innovations are making fertility treatments more efficient, accessible, and successful, opening up new possibilities for individuals and couples seeking to build families.

What Factors Are Driving the Growth of the Fertility Services Market?

Several key factors are driving the growth of the fertility services market, including the rising prevalence of infertility, delayed childbearing, advancements in reproductive technologies, and increasing societal acceptance of fertility treatments. One of the primary drivers is the growing global incidence of infertility, which is affecting both men and women. Factors such as lifestyle changes, environmental pollutants, stress, and medical conditions like obesity and polycystic ovary syndrome (PCOS) are contributing to rising infertility rates. As more people face challenges in conceiving naturally, the demand for fertility services continues to rise, with treatments like IVF, IUI, and fertility preservation becoming more commonplace.

Another significant factor contributing to the growth of the fertility services market is the trend toward delayed childbearing. With more women prioritizing their careers, education, and personal goals, many are choosing to have children later in life. However, age is a critical factor in fertility, particularly for women, as fertility declines with age. Fertility services, including egg freezing and IVF, provide solutions for women who wish to preserve their fertility and conceive later in life, leading to increased demand for these services. Additionally, with the rise in second marriages and blended families, fertility services are being used by older individuals or couples who wish to have children together, further driving market growth.

Advancements in reproductive technologies are also playing a crucial role in the expansion of the fertility services market. Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and cryopreservation techniques have improved the success rates of fertility treatments, making them more appealing to individuals and couples seeking reproductive assistance. The integration of AI and machine learning in fertility clinics is further enhancing treatment outcomes by providing more personalized care and optimizing treatment strategies. These technological advancements are making fertility treatments more effective and accessible, encouraging more people to explore fertility options.

The growing societal acceptance of fertility treatments is another major factor driving market growth. Fertility treatments, once considered taboo or stigmatized, are now widely accepted and embraced, especially in developed countries. Public figures and celebrities openly discussing their fertility journeys have helped to reduce the stigma around infertility, encouraging more people to seek fertility services. Moreover, legal and social advancements, such as the recognition of same-sex marriages and the availability of surrogacy and donor programs, are providing new pathways for LGBTQ+ individuals and single parents to build families. As these treatments become more accessible and normalized, the fertility services market continues to expand.

Increasing government support and healthcare coverage for fertility treatments are also driving the growth of the market. In many countries, insurance companies and healthcare systems are beginning to cover a portion of the costs associated with fertility treatments like IVF, making them more affordable for a broader population. Government initiatives that promote reproductive health and provide financial assistance for fertility treatments are also helping to increase access to these services. In regions where fertility rates are declining, governments are investing in fertility treatments as part of national efforts to boost population growth, further contributing to the expansion of the market.

In conclusion, the fertility services market is poised for significant growth as more individuals and couples seek reproductive assistance to overcome infertility, delay parenthood, or pursue non-traditional family-building options. With advancements in reproductive technologies, growing societal acceptance, and increasing access to fertility services, the industry is set to play an even larger role in helping people realize their dreams of parenthood. As fertility treatments continue to evolve and improve, they will provide more inclusive, effective, and personalized care, revolutionizing the landscape of reproductive health and family planning worldwide.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Fertility Services - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Infertility Rates Driving Demand for Fertility Services
    • Advancements in Assisted Reproductive Technologies (ART) Enhancing Success Rates
    • Growing Acceptance and Legalization of IVF and Surrogacy Across Different Regions
    • Market Trends Toward Personalized Treatment Plans Based on Genetic Testing
    • Future Directions: Integration of AI and Machine Learning in Fertility Treatment Protocols
    • Technological Innovations in Embryo Screening and Preservation Techniques
    • Global Increase in Same-Sex Couples and Single Parents Using Fertility Services
    • Regulatory and Ethical Considerations in Egg and Sperm Donation
    • Development of Mobile Apps and Online Platforms for Fertility Consultation and Management
    • Market Response to Growing Trends in Egg Freezing for Career Planning
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fertility Services Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Egg & Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Clinical Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • JAPAN
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • CHINA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • EUROPE
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • FRANCE
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • GERMANY
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • INDIA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030
  • AFRICA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2014, 2024 & 2030

IV. COMPETITION